130 related articles for article (PubMed ID: 7377646)
1. [P-450 cytochromes and mono-oxygenases. Mechanism of action. Consequences in pharmacology and toxicology (author's transl)].
Mansuy D
Ann Biol Clin (Paris); 1980; 38(1):19-23. PubMed ID: 7377646
[TBL] [Abstract][Full Text] [Related]
2. [Development of the mono-oxygenase system. Implications in perinatal pharmacotoxicology (author's transl)].
Cresteil T; Leroux P
Ann Biol Clin (Paris); 1980; 38(1):57-65. PubMed ID: 6990843
[TBL] [Abstract][Full Text] [Related]
3. [Capacity limited pharmacokinetics, a mechanism of drug toxicity (author's transl)].
Dettli L
Arzneimittelforschung; 1977; 27(96):1844-8. PubMed ID: 579151
[TBL] [Abstract][Full Text] [Related]
4. [The role of cytochrome P450 in the activation of drugs (author's transl)].
Ullrich V
Arzneimittelforschung; 1977; 27(96):1821-7. PubMed ID: 579147
[TBL] [Abstract][Full Text] [Related]
5. Toxicological implications of drug metabolism.
Welch RM
Pharmacol Rev; 1978 Dec; 30(4):457-67. PubMed ID: 392540
[No Abstract] [Full Text] [Related]
6. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs].
Ackermann E
Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493
[No Abstract] [Full Text] [Related]
7. Biotransformation of drugs in human skin.
Svensson CK
Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
[TBL] [Abstract][Full Text] [Related]
8. Drug-drug interactions: how scared should we be?
Shapiro LE; Shear NH
CMAJ; 1999 Nov; 161(10):1266-7. PubMed ID: 10584089
[No Abstract] [Full Text] [Related]
9. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
[TBL] [Abstract][Full Text] [Related]
10. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
Gillette JR
Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome p450 and chemical toxicology.
Guengerich FP
Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
[TBL] [Abstract][Full Text] [Related]
12. New techniques in drug metabolism and clinical pharmacology/pharmacokinetics.
Benet LZ
Am Biotechnol Lab; 1993 Feb; 11(2):44-7. PubMed ID: 7763426
[No Abstract] [Full Text] [Related]
13. [Drug-induced hepatits: the role of unstable metabolites (author's transl)].
Pessayre D; Benhamou JP
Acta Gastroenterol Belg; 1978; 41(9-10):574-86. PubMed ID: 735686
[No Abstract] [Full Text] [Related]
14. The use of deuterium isotope effects to probe the active site properties, mechanism of cytochrome P450-catalyzed reactions, and mechanisms of metabolically dependent toxicity.
Nelson SD; Trager WF
Drug Metab Dispos; 2003 Dec; 31(12):1481-98. PubMed ID: 14625345
[TBL] [Abstract][Full Text] [Related]
15. The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
Werner M; Birner G; Dekant W
Drug Metab Dispos; 1995 Aug; 23(8):861-8. PubMed ID: 7493554
[TBL] [Abstract][Full Text] [Related]
16. [Species differences in drug metabolism - overview from animals to man (author's transl)].
Kato R
Jikken Dobutsu; 1981 Oct; 30(4):507-17. PubMed ID: 7318948
[No Abstract] [Full Text] [Related]
17. Considerations of toxicologic interactions in developing new chemicals.
Wilkinson CF; Murray M
Drug Metab Rev; 1984; 15(5-6):897-917. PubMed ID: 6396059
[No Abstract] [Full Text] [Related]
18. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
Chen L; Waxman DJ
Cancer Res; 1995 Feb; 55(3):581-9. PubMed ID: 7834628
[TBL] [Abstract][Full Text] [Related]
20. Interactive binding at cytochrome P-450 of cell growth regulatory bioamines, steroid hormones, antihormones, and drugs.
LaBella FS; Queen GM; Brandes LJ
J Cell Biochem; 2000 Jan; 76(4):686-94. PubMed ID: 10653987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
